Related Experiment Video
Updated: Dec 26, 2025

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
How could hypoglycemia-inducing glycogen storage disease lead to hyperglycemia-induced mucormycosis?
Larry Nichols1, Diana Alejandra Rios2
1Mercer University School of Medicine, Department of Pathology. Macon, GA, United States of America.
Abstract:
Mucormycosis is an increasingly frequent, difficult to diagnose, difficult to treat, often fatal infection, especially in patients with hyperglycemia from uncontrolled diabetes. Type I (von Gierke) glycogen storage disease is due to inherited deficiency of enzymes in glycogen metabolism, which causes hypoglycemia. This report is the case of a patient with von Gierke disease and a missed diagnosis of pulmonary mucormycosis. This report illustrates the importance of having a high index of suspicion for mucormycosis in the appropriate clinical context.
Insights
Mucormycosis, a dangerous fungal infection, is often missed in patients with von Gierke disease, a condition causing low blood sugar. Early suspicion is crucial for timely diagnosis and treatment of this often-fatal infection.
Area of Science:
- Medical Mycology
- Metabolic Disorders
- Clinical Case Reports
Background:
- Mucormycosis is a severe, invasive fungal infection with high mortality, particularly in immunocompromised individuals.
- Hyperglycemia in uncontrolled diabetes is a known risk factor for mucormycosis.
- Type I glycogen storage disease (von Gierke disease) is characterized by hypoglycemia due to enzyme deficiencies in glycogen metabolism.
Purpose of the Study:
- To report a case of pulmonary mucormycosis in a patient with von Gierke disease.
- To highlight the diagnostic challenges and clinical importance of considering mucormycosis in specific patient populations.
- To emphasize the need for a high index of suspicion for mucormycosis in patients with metabolic disorders.
Main Methods:
- Case report presentation.
- Review of clinical presentation, diagnostic workup, and treatment of the patient.
- Discussion of the interplay between von Gierke disease and mucormycosis risk.
Main Results:
- A patient with von Gierke disease presented with symptoms suggestive of a pulmonary infection.
- The diagnosis of pulmonary mucormycosis was initially missed.
- The case underscores the potential for atypical presentations of mucormycosis.
Conclusions:
- Mucormycosis can occur in patients with von Gierke disease, despite the typical association with hyperglycemia.
- A high index of suspicion is essential for diagnosing mucormycosis in patients with underlying metabolic disorders.
- Prompt diagnosis and treatment are critical for improving outcomes in mucormycosis.
More Related Videos
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Fungal Group Zygomycota
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: